CNE1000016C2
CNE1000016C2
CHANGSHAN PHARMA
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 20.36B EUR | 21.52B EUR | 34.35B EUR |
Enterprise Value | 22.94B EUR | 24.13B EUR | 36.84B EUR |
Valuation Multiples | |||
Trailing P/E | -- | -- | -- |
Forward P/E | -- | -- | -- |
Price to Sales | 23.69x | 23.85x | 36.48x |
Price to Book | 17.14x | 18.12x | 28.39x |
EV/Revenue | 26.69x | 26.73x | 39.13x |
EV/EBITDA | -151.59x | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -0.87% | -0.62% | -0.06% |